NRP1 and carcinoma: In the present study, we investigated the effects of the NRP1 antagonist EG3287 on cell proliferation, survival, migration, and adhesion to matrix in the NRP1-expressing carcinoma cell lines, non-small-cell lung A549, kidney ACHN, and prostate DU145 cells.